| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.8M | +28.0% | -5.4% |
| Cost of Revenue | $4.5M | -1.2% | +1.6% |
| R&D Expense | $4.5M | +10.4% | -14.0% |
| SG&A Expense | $15.3M | +20.0% | +25.8% |
| Operating Income | -$11.5M | -1.0% | -38.5% |
| Pre-tax Income | -$15.4M | -14.0% | -34.2% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $129.1M | +113.2% | +65.7% |
| Inventory | $7.9M | -3.0% | +12.3% |
| Current Assets | $151.7M | +85.6% | +57.1% |
| Total Assets | $163.6M | +74.6% | +48.7% |
| Current Liabilities | $25.6M | +10.4% | +68.8% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.0M | — | — |
| Capital Expenditures | $477K | — | — |
| Investing Cash Flow | -$477K | — | — |
| Financing Cash Flow | $102.0M | — | — |
| Free Cash Flow | -$44.4M | — | — |
| — |
| — |
| Net Income | -$15.4M | -14.0% | -34.2% |
| EPS (Basic) | -$0.14 | +0.0% | -7.7% |
| EPS (Diluted) | -$0.14 | +0.0% | -7.7% |
| $45.0M |
| +0.0% |
| +0.0% |
| Total Liabilities | $167.7M | +0.8% | +7.9% |
| Stockholders' Equity | -$4.1M | +94.3% | +91.0% |